CC16 augmentation reduces exaggerated COPD-like disease in Cc16-deficient mice.

Rojas-Quintero J, Laucho-Contreras ME, Wang X, Fucci QA, Burkett PR, Kim SJ, Zhang D, Tesfaigzi Y, Li Y, Bhashyam AR, Li Z, Khamas H, Celli B, Pilon AL, Polverino F, Owen CA. CC16 augmentation reduces exaggerated COPD-like disease in Cc16-deficient mice. JCI Insight. 2023 03 22; 8(6).

View in: PubMed

subject areas

Animals
Humans
Lung
Mice
NF-kappa B
Pneumonia
Pulmonary Disease, Chronic Obstructive
Pulmonary Emphysema

authors with profiles

Yohannes Tesfaigzi

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support